作者: RICHARD M. LUCERI , RICHARD J. THURER , GEORGE M. PALATIANOS , PEDRO R. FERNANDEZ , ASHRAF EL-SHALAKANY
DOI: 10.1111/J.1540-8159.1986.TB06721.X
关键词:
摘要: The automatic implantable cardioverter-defibrillator (AICD) is a device of proven efficacy in life-threatening ventricular tachycardia and fibrillation. Initial experience with the AICD at University Miami consists 21 patients recurrent dysrhythmias for total follow-up 3-35 months (mean 19). There were two deaths series, one nonarrhythmic arrhythmic, fifth tenth postoperative respectively. five complications requiring reoperation three patients. Pacemakers required four resulted interesting observations. Our data concur previously published reports improved survival selected